Silodosin in Management of Lower Ureteral Stones

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-20

Study Completion Date

2023-10-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research aims to study the effectiveness of silodosin in the management of lower ureter stones larger than 6 mm in diameter in terms of affected ureter (right or left), the size of the stone, the degree of hydronephrosis, the rate of stone expulsion(day), whether the stone was completely expelled or not, and the side effects of silodosin.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Silodosin in Retrograde Intrarenal Surgery

NCT05921370

Urolithiasis

COMPLETED PHASE3

Silodosin in Facilitating Flexible Uretroscopy

NCT07068087

Stone Ureter Stone, Kidney

ACTIVE_NOT_RECRUITING NA

Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones

NCT01533389

Ureteral Stone

COMPLETED PHASE4

Study of Silodosin to Facilitate Passage of Urinary Stones

NCT01144949

Ureteral Calculi Kidney Stones Urolithiasis

COMPLETED PHASE2

COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI

NCT05790902

Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stone, Kidney

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

case group

patients who had given silodosin

Group Type EXPERIMENTAL

Silodosin

Intervention Type DRUG

Selective Alpha Blocker drug

Control group

patients who had not given silodosin

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Silodosin

Selective Alpha Blocker drug

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients attending the urology Clinic with a distal unilateral ureteral stone larger than 6 mm in diameter.

Exclusion Criteria

* Patients under 18 years of age
* Pregnant women
* Patients with whom we were unable to contact
* Patients treated with silodosin for another reason
* Single kidney patients
* Patients with bilateral ureter stones
* Patients with deteriorating kidney function
* Patients with grades 3rd and 4th of hydronephrosis

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No